Reduced neutralizing antibody production against Omicron XBB.1.5 in people living with HIV

作     者：Jiaying Zhang Jiming Yin Wenjing Wang Juanli Gao Tongzeng Li Danlei Mou Lianchun Liang Qinghua Meng Yingmei Feng Jiaying Zhang;Jiming Yin;Wenjing Wang;Juanli Gao;Tongzeng Li;Danlei Mou;Lianchun Liang;Qinghua Meng;Yingmei Feng

作者机构：Department of Infectious DiseasesBeijing Youan HospitalCapital Medical UniversityBeijing 100069China Beijing Institute of HepatologyBeijing Youan HospitalCapital Medical UniversityBeijing 100069China Department of Medical OncologyBeijing Youan HospitalCapital Medical UniversityBeijing 100069China Department of Science and DevelopmentBeijing Youan HospitalCapital Medical UniversityBeijing 100069China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志(英文版))

年 卷 期：2024年第137卷第21期

页      面：2633-2635页

核心收录：

学科分类：0202[经济学-应用经济学] 02[经济学] 020205[经济学-产业经济学] 

基　　金：supported by a grant from the National Key R&D Program of China(No.2023YFC0872400) 

主　　题：capacity gained neutral 

摘      要：To the Editor:The emergence of Omicron has gained global attention since November *** the Omicron strains,Omicron XBB.1.5 is the most recently *** carries deletions and more than 30 mutations,which have modified the biological features of severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)for enhanced transmissibility and immune escape capacity.